While I disagree that we won’t get FDA approval. I do agree that we are well positioned now that “if” that’s a massive “if” we didn’t get FDA we have de-risked exponentially from receiving European and Australian approvals, with sleep apnea applications in the pipeline, not to mention Lockheed Martin partnership progression or any other left field announcements. So from a risk basis there are many reason not to be concerned about it. Rest assured that if you hold RAP currently you can sleep at night knowing the company is going places! We are just waiting for the cherry to be put on top now!
RAP Price at posting:
33.5¢ Sentiment: Buy Disclosure: Held